FDA adds additional block box warnings of death and tumor growth to anemia drugs

Drug maker Amgen Inc. says regulators have added new warnings about risks of death and tumor growth to its blockbuster anemia drugs.

The new warnings approved by the Food and Drug Administration
warn that the company's drugs increased death and accelerated tumor
growth in patients with several types of cancer, including breast
and cervical. Prior labeling warned of similar risks in other types
of cancers

The warnings also apply to Thousand Oaks, Calif.-based Amgen's
Aranesp and Epogen, as well as Procit, made by New Brunswick,
N.J-based Johnson & Johnson.

You must be logged in to post comments.

Password (case sensitive):
Remember Me:

275 E. Arlington Blvd. Greenville, NC 27858 252-439-7777
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 16403141 - witn.com/a?a=16403141
Gray Television, Inc.